In continuation of the challenges arising from the roll-out of India's new drug pricing policy, a question has now been raised on the current National List of Essential Medicines (NLEM) that specifies the universe of drugs under price control. "Some may argue that the NLEM is not appropriately designed," said Dilsher Singh Kalha, Secretary, Department … Continue reading India & drug pricing : Now, list of essential meds questioned
Apothecurry 